MindMaze Therapeutics Announces Results of Annual General Meeting

GENEVA, June 25, 2026 /PRNewswire/ — MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced the results of its Annual General Meeting held earlier today. Shareholders approved…

Read the full release →

News provided by PR Newswire.